Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Julaine (TM) for the Treatment of Atrophic Facial Acne Scars

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07058883) titled 'A Randomized, Double-Blind, Placebo-Controlled Study Evaluating Julaine (TM) for the Treatment of Atrophic Facial Acne Scars' on July 01.

Brief Summary: This study aims to evaluate the effectiveness and safety of Julaine, an injectable medical device made of polylactic acid, for treating facial acne scars. Participants with atrophic acne scars will be randomly assigned to receive either Julaine or a placebo (saline). The treatment will consist of three injection sessions over two months, followed by a 12-month observation period. The study will measure changes in scar severity and skin quality over time using clinical assessments an...